Skip to content

ARCH Venture Partners X, L.P.

Reporting owner on Forms 3, 4 and 5, CIK 1782583.

ARCH Venture Partners X, L.P. reported on 1 issuer in 4 filings, the latest a 13D/A filed 2026-11-13.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Aspen Neuroscience, Inc. CIK 212408010% owner22026-11-02

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Aspen Neuroscience, Inc. Common Stock2026-11-02P bought+66,666$1566,666Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+187,182253,848Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+298,258552,106Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+286,304838,410Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+295,4901,133,900Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+259,9481,393,848Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02P bought+66,667$1566,667Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+298,258364,925Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+286,304651,229Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+295,490946,719Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+214,3551,161,074Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02P bought+1,200,000$151,200,000Form 4
Aspen Neuroscience, Inc. Series Seed Convertible Preferred Stock, derivative2026-11-02C converted-187,1820Form 4
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative2026-11-02C converted-298,2580Form 4
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative2026-11-02C converted-298,2580Form 4
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative2026-11-02C converted-286,3040Form 4
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative2026-11-02C converted-286,3040Form 4
Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative2026-11-02C converted-295,4900Form 4
Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative2026-11-02C converted-295,4900Form 4
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative2026-11-02C converted-259,9480Form 4
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative2026-11-02C converted-214,3550Form 4
Aspen Neuroscience, Inc. Series Seed Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0001193125-26-460600 PRME2026-11-13
13D 0001193125-26-454047 ASPE2026-11-09
Form 4 0001193125-26-444147 Aspen Neuroscience, Inc.2026-11-02
Form 3 0001193125-26-439136 Aspen Neuroscience, Inc.2026-10-29